Clinical Trials Browser

Phase 1/2 × Has results × Aminolevulinic Acid × Clear all

NCT01128218 2023-11-30

A Study of the Specificity and Sensitivity of 5- Aminolevulinic Acid (ALA) Fluorescence in Malignant Brain Tumors

Phase 1/2 Completed

33 enrolled 15 charts

Brain Neoplasms, Glioblastoma, Glioma

NCT00571974 2015-03-24

Treatment of Oral Premalignant Lesions With 5-ALA PDT

Phase 1/2 Completed

29 enrolled 6 charts

Erythroplasia, Leukoplakia